SENOKOTXTRA- standardized senna concentrate tablet 
Purdue Products LP

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.


(standardized senna concentrate)

Drug Facts

Active ingredient (in each tablet) Purpose

Sennosides 17.2 mg




  • relieves occasional constipation (irregularity)
  • generally causes bowel movement in 6-12 hours


Do not use

  • laxative products for longer than 1 week unless directed by a doctor

Ask a doctor before use if you have

  • stomach pain
  • nausea
  • vomiting
  • noticed a sudden change in bowel movements that continues over a period of 2 weeks

Stop use and ask a doctor if you have rectal bleeding or fail to have a bowel movement after use of a laxative. These may indicate a serious condition.

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.


  • take preferably at bedtime or as directed by a doctor
agestarting dosagemaximum dosage
adults and children 12 years of age and over1 tablet
once a day
2 tablets
twice a day
children 6 to under 12 years1/2 tablet
once a day
1 tablet
twice a day
children under 6ask a doctorask a doctor

Other information

  • each tablet contains: calcium 20 mg
  • store at 25°C (77°F); excursions permitted between 15°-30°C (59°-86°F)

Inactive ingredients croscarmellose sodium, dicalcium phosphate, hypromellose, lactose, magnesium stearate, microcrystalline cellulose, mineral oil, stearic acid, talc, tartaric acid

©2011, Purdue Products L.P.

Dist. by: Purdue Products L.P., Stamford, CT 06901-3431



12 Tablets

SenokotXTRA Tablets NDC 67618-315-12
standardized senna concentrate tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:67618-315
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Inactive Ingredients
Ingredient NameStrength
croscarmellose sodium (UNII: M28OL1HH48)  
anhydrous lactose (UNII: 3SY5LH9PMK)  
magnesium stearate (UNII: 70097M6I30)  
cellulose, microcrystalline (UNII: OP1R32D61U)  
mineral oil (UNII: T5L8T28FGP)  
stearic acid (UNII: 4ELV7Z65AP)  
tartaric acid (UNII: W4888I119H)  
hypromelloses (UNII: 3NXW29V3WO)  
anhydrous dibasic calcium phosphate (UNII: L11K75P92J)  
Product Characteristics
ColorBROWN (Light Brown) Scoreno score
FlavorImprint Code X
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:67618-315-121 in 1 CARTON09/01/198812/31/2022
112 in 1 BLISTER PACK; Type 0: Not a Combination Product
2NDC:67618-315-363 in 1 CARTON09/01/198801/01/2014
212 in 1 BLISTER PACK; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph not finalpart33409/01/198812/31/2022
Labeler - Purdue Products LP (141916531)
Registrant - Purdue Pharma LP (932323652)
NameAddressID/FEIBusiness Operations
Contract Pharmacal Corporation968334974MANUFACTURE(67618-315)

Revised: 9/2023
Purdue Products LP